You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Cetyl alcohol; colfosceril palmitate; tyloxapol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cetyl alcohol; colfosceril palmitate; tyloxapol and what is the scope of freedom to operate?

Cetyl alcohol; colfosceril palmitate; tyloxapol is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for cetyl alcohol; colfosceril palmitate; tyloxapol
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
DailyMed Link:cetyl alcohol; colfosceril palmitate; tyloxapol at DailyMed

US Patents and Regulatory Information for cetyl alcohol; colfosceril palmitate; tyloxapol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline EXOSURF NEONATAL cetyl alcohol; colfosceril palmitate; tyloxapol FOR SUSPENSION;INTRATRACHEAL 020044-001 Aug 2, 1990 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for cetyl alcohol; colfosceril palmitate; tyloxapol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline EXOSURF NEONATAL cetyl alcohol; colfosceril palmitate; tyloxapol FOR SUSPENSION;INTRATRACHEAL 020044-001 Aug 2, 1990 ⤷  Subscribe ⤷  Subscribe
Glaxosmithkline EXOSURF NEONATAL cetyl alcohol; colfosceril palmitate; tyloxapol FOR SUSPENSION;INTRATRACHEAL 020044-001 Aug 2, 1990 ⤷  Subscribe ⤷  Subscribe
Glaxosmithkline EXOSURF NEONATAL cetyl alcohol; colfosceril palmitate; tyloxapol FOR SUSPENSION;INTRATRACHEAL 020044-001 Aug 2, 1990 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Cetyl alcohol; colfosceril palmitate; tyloxapol Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Cetyl Alcohol, Colfosceril Palmitate, and Tyloxapol

Introduction

Cetyl alcohol, colfosceril palmitate, and tyloxapol are components of various pharmaceutical and cosmetic products, with significant market presence and financial implications. This article delves into the market dynamics, financial trajectory, and key factors influencing these compounds.

Market Overview of Cetyl Alcohol

Global Market Size and Growth

The global cetyl stearyl alcohol market, which includes cetyl alcohol, is projected to grow at a CAGR of 3.78% from 2024 to 2029, reaching a substantial market size by the end of the forecast period[1][4].

Regional Market Performance

Europe is the largest market for cetyl stearyl alcohol, driven by a robust cosmetics industry in countries like Germany, France, the UK, and Italy. The Asia Pacific region is expected to be the fastest-growing market due to increasing demand for cosmetic and skincare products[1].

Key Players

Major players in the cetyl stearyl alcohol market include Prakash Chemicals Pvt Ltd, Jacob Stern & Sons Inc., Kao Corporation, Aromantic Ltd, and Procter and Gamble Company. These companies are focusing on innovative applications and consumer needs to maintain market share[1].

Pharmaceutical Applications: Colfosceril Palmitate, Cetyl Alcohol, and Tyloxapol

Exosurf Neonatal

One notable pharmaceutical application is Exosurf Neonatal for Intratracheal Suspension, which contains colfosceril palmitate, cetyl alcohol, and tyloxapol. This product is approved for the prevention and treatment of hyaline membrane disease (respiratory distress syndrome) in premature infants[3].

Market Impact

The approval and marketing of such specialized pharmaceuticals contribute to the overall demand for these ingredients. The orphan designation and approval of Exosurf Neonatal highlight the critical role these compounds play in niche but vital medical applications.

Financial Trajectory

Market Size and Forecast

The cetyl stearyl alcohol market, which encompasses cetyl alcohol, was valued at USD 752.99 million in 2023 and is projected to reach USD 977.92 million by 2030, growing at a CAGR of 3.5% during the forecast period[4].

Economic Factors

The financial trajectory of these compounds is influenced by broader economic factors, such as interest rates and corporate borrowing strategies. With central bank policy rates likely at or near their peak, companies may postpone market activities in anticipation of rate cuts, which could impact the financing conditions for manufacturers of these ingredients[5].

Industry Trends and Challenges

Adaptation to Market Changes

The COVID-19 pandemic has accelerated changes in market dynamics, with companies adapting to new normals. This adaptation process, as seen in other industries, brings new winners and losers. For example, high-growth companies have performed well, while slower, more mature companies have faced challenges[2].

Consumer Demand

The growing demand for customized cosmetic products, especially among millennials, drives the market for cetyl alcohol and other related compounds. This trend is expected to continue, supporting the growth of the cetyl stearyl alcohol market[1].

Competitive Landscape

Market Concentration

The cetyl stearyl alcohol market is fragmented, with both global and regional players competing. The presence of numerous small and medium-sized manufacturers adds to the competitive landscape, making it an attractive market for new entrants[1].

Innovation and Consumer Needs

Existing manufacturers are focusing on innovative applications and meeting consumer needs to stay competitive. This includes developing new ways to use cetyl alcohol and other related compounds in skincare, cosmetics, and medicinal applications[1].

Regulatory Environment

FDA Approvals

The FDA approval of products like Exosurf Neonatal for specific medical conditions ensures that these compounds meet stringent regulatory standards. This regulatory oversight is crucial for maintaining market credibility and ensuring the safety and efficacy of products containing cetyl alcohol, colfosceril palmitate, and tyloxapol[3].

Future Outlook

Growth Prospects

The future outlook for cetyl alcohol, colfosceril palmitate, and tyloxapol is positive, driven by growing demand in the cosmetics and pharmaceutical sectors. The Asia Pacific region's rapid growth and Europe's established market will continue to drive the global market forward[1][4].

Economic Considerations

As interest rates stabilize and economic conditions evolve, companies will need to adapt their strategies to optimize financing and market activities. This could involve postponing certain market activities or seeking alternative financing options[5].

Key Takeaways

  • The global cetyl stearyl alcohol market is expected to grow at a CAGR of 3.78% from 2024 to 2029.
  • Europe is the largest market, while the Asia Pacific region is the fastest-growing.
  • Key players include Prakash Chemicals Pvt Ltd, Jacob Stern & Sons Inc., Kao Corporation, Aromantic Ltd, and Procter and Gamble Company.
  • Exosurf Neonatal, containing colfosceril palmitate, cetyl alcohol, and tyloxapol, is a significant pharmaceutical application.
  • Economic factors such as interest rates will influence the financial trajectory of these compounds.
  • The market is driven by consumer demand for customized cosmetic products and innovative applications.

FAQs

What is the projected CAGR for the cetyl stearyl alcohol market?

The global cetyl stearyl alcohol market is projected to register a CAGR of 3.78% over the next five years[1].

Which region is the largest market for cetyl stearyl alcohol?

Europe accounts for the largest market share in the cetyl stearyl alcohol market[1].

What is the primary pharmaceutical application of colfosceril palmitate, cetyl alcohol, and tyloxapol?

The primary pharmaceutical application is Exosurf Neonatal for Intratracheal Suspension, used to prevent and treat hyaline membrane disease in premature infants[3].

How do economic factors influence the market for these compounds?

Economic factors such as interest rates and corporate borrowing strategies can impact the financing conditions and market activities of manufacturers, potentially affecting the market size and growth[5].

Who are the major players in the cetyl stearyl alcohol market?

Major players include Prakash Chemicals Pvt Ltd, Jacob Stern & Sons Inc., Kao Corporation, Aromantic Ltd, and Procter and Gamble Company[1].

Sources

  1. Mordor Intelligence: Cetyl Stearyl Alcohol Market Size & Share Analysis - Growth Trends
  2. MIT Sloan Virtual Reunion 2021: Making Sense of Financial Market Dynamics in a Post-COVID World
  3. FDA: Search Orphan Drug Designations and Approvals - FDA
  4. Verified Market Research: Cetyl Stearyl Alcohol Market Size, Share, Trends & Forecast
  5. S&P Global: Market Dynamics: How Will The Path Of Interest Rates In 2024 Affect Corporate Borrowing Strategies

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.